# Trade Mark Journal No.2025/024 13 June 2025

## UK00004210806 29 May 2025 (1,5,42,44)

Mark 1

Mark 2

Mark 3

Class 1
  Chemicals for use in industry and science; biochemicals, including polypeptides and antibodies for scientific, laboratory or research purposes; polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; ion channel blocking antibodies for scientific, laboratory or research purposes; ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs.
Class 5
  Pharmaceuticals and pharmaceutical preparations; drugs; antibodies for medical use; pharmaceuticals, drugs and pharmaceutical preparations incorporating antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; vaccines.
Class 42
  Scientific and technological services and research and design relating thereto; drug discovery and drug development services; conducting or providing research and development services for others in the field of antibodies; laboratory services relating to the production of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; antibody engineering; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; information, advisory and consultancy services in relation to all of the aforesaid. .
Class 44
  Medical services; medical testing, analysis and diagnostic services in the field of antibodies; medical services connected with the treatment of diseases through the use of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid; information, advisory and consultancy services in relation to all of the aforesaid.

Maxion Therapeutics Limited

Representative: Stratagem Intellectual Property Management Limited